Cite
APA Citation
Navid, F., Santana, V. M., Neel, M., McCarville, M. B., Shulkin, B. L., Wu, J., Billups, C. A., Mao, S., Daryani, V. M., Stewart, C. F., Kunkel, M., Smith, W., Ward, D., Pappo, A. S., Bahrami, A., Loeb, D. M., Reikes Willert, J., Rao, B. N., & Daw, N. C. (n.d.). a phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy. International journal of cancer, 141(7), 1469–1477. http://access.bl.uk/ark:/81055/vdc_100048092931.0x000060